lobbying_activities: 966741

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id filing_uuid filing_type registrant_name registrant_id client_name filing_year filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
966741 a306523f-dfb0-4df9-b161-d7516341ca55 Q2 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2010 second_quarter PHA S 726 Promoting Innovation and Access to Life-Saving Medicine Act To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products. Sponsor: Schumer (D-NY) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   140000 0 0 2010-07-19T19:39:49.010000-04:00